Vaccination Undermined

For more than 200 years, vaccines have made an unparalleled contribution to public health. The writer and commentator Samuel Butler (1835-1902) wrote: "Vaccination is the medical sacrament corresponding to baptism." Considering the list of killer diseases that once held terror and are now under control, including polio, measles, diphtheria, pertussis, rubella, mumps, tetanus, and Haemophilus influenzae type b (Hib), one might expect vaccination to have achieved miracle status, not just sacrame

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For more than 200 years, vaccines have made an unparalleled contribution to public health. The writer and commentator Samuel Butler (1835-1902) wrote: "Vaccination is the medical sacrament corresponding to baptism." Considering the list of killer diseases that once held terror and are now under control, including polio, measles, diphtheria, pertussis, rubella, mumps, tetanus, and Haemophilus influenzae type b (Hib), one might expect vaccination to have achieved miracle status, not just sacramental.

Unfortunately, this could hardly be farther from the truth. Vaccines are unattractive targets for industry, underappreciated from the public health perspective, underfunded by basic research organizations, and treated with suspicion by the public. Multiple reasons exist for this, but the one that gets me steamed is the malign influence of three groups: antivaccine lobbyists, journalists, and lawyers.

The antivaccine lobby strikes me as ignorant. A simple Web search turns up numerous sites that are virulently antivaccination.1 Often these sites ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Richard Gallagher

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo